Can we afford to pay for future cures?
Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging
Where pharma comes to life
Close log in window
A new decade is here. And despite the incredible science, pharma is ill-equipped.
Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust
The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value
Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthc...
